227 related articles for article (PubMed ID: 24332968)
1. Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.
Tornovsky-Babeay S; Dadon D; Ziv O; Tzipilevich E; Kadosh T; Schyr-Ben Haroush R; Hija A; Stolovich-Rain M; Furth-Lavi J; Granot Z; Porat S; Philipson LH; Herold KC; Bhatti TR; Stanley C; Ashcroft FM; In't Veld P; Saada A; Magnuson MA; Glaser B; Dor Y
Cell Metab; 2014 Jan; 19(1):109-21. PubMed ID: 24332968
[TBL] [Abstract][Full Text] [Related]
2. Metabolism: DNA double-strand breaks and p53 activity in β-cell failure.
Koch L
Nat Rev Endocrinol; 2014 Mar; 10(3):126. PubMed ID: 24366124
[No Abstract] [Full Text] [Related]
3. Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes.
Tornovsky-Babeay S; Weinberg-Corem N; Ben-Haroush Schyr R; Avrahami D; Lavi J; Feleke E; Kaestner KH; Dor Y; Glaser B
Diabetologia; 2021 May; 64(5):1133-1143. PubMed ID: 33558985
[TBL] [Abstract][Full Text] [Related]
4. Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes.
Lu M; Li C
Ann N Y Acad Sci; 2018 Jan; 1411(1):65-82. PubMed ID: 29044608
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 enhances glucokinase activity in pancreatic β-cells through the association of Epac2 with Rim2 and Rab3A.
Park JH; Kim SJ; Park SH; Son DG; Bae JH; Kim HK; Han J; Song DK
Endocrinology; 2012 Feb; 153(2):574-82. PubMed ID: 22147008
[TBL] [Abstract][Full Text] [Related]
6. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
7. Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus.
Hussain K
Rev Endocr Metab Disord; 2010 Sep; 11(3):179-83. PubMed ID: 20878480
[TBL] [Abstract][Full Text] [Related]
8. Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.
Lin YW; Bushman JD; Yan FF; Haidar S; MacMullen C; Ganguly A; Stanley CA; Shyng SL
J Biol Chem; 2008 Apr; 283(14):9146-56. PubMed ID: 18250167
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells.
Ding SY; Nkobena A; Kraft CA; Markwardt ML; Rizzo MA
J Biol Chem; 2011 May; 286(19):16768-74. PubMed ID: 21454584
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism.
Chen PC; Olson EM; Zhou Q; Kryukova Y; Sampson HM; Thomas DY; Shyng SL
J Biol Chem; 2013 Jul; 288(29):20942-20954. PubMed ID: 23744072
[TBL] [Abstract][Full Text] [Related]
11. Genetic Reduction of Glucose Metabolism Preserves Functional β-Cell Mass in KATP-Induced Neonatal Diabetes.
Yan Z; Fortunato M; Shyr ZA; Clark AL; Fuess M; Nichols CG; Remedi MS
Diabetes; 2022 Jun; 71(6):1233-1245. PubMed ID: 35294000
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Origins of Enzyme Activation in Human Glucokinase Variants Associated with Congenital Hyperinsulinism.
Sternisha SM; Liu P; Marshall AG; Miller BG
Biochemistry; 2018 Mar; 57(10):1632-1639. PubMed ID: 29425029
[TBL] [Abstract][Full Text] [Related]
14. beta-cell failure in diabetes and preservation by clinical treatment.
Wajchenberg BL
Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet.
Nakaya K; Kubota N; Takamoto I; Kubota T; Katsuyama H; Sato H; Tokuyama K; Hashimoto S; Goto M; Jomori T; Ueki K; Kadowaki T
Metabolism; 2013 Jul; 62(7):939-51. PubMed ID: 23790528
[TBL] [Abstract][Full Text] [Related]
16. From congenital hyperinsulinism to diabetes mellitus: the role of pancreatic beta-cell KATP channels.
Hussain K; Cosgrove KE
Pediatr Diabetes; 2005 Jun; 6(2):103-13. PubMed ID: 15963039
[TBL] [Abstract][Full Text] [Related]
17. Selective ablation of P53 in pancreatic beta cells fails to ameliorate glucose metabolism in genetic, dietary and pharmacological models of diabetes mellitus.
Uhlemeyer C; Müller N; Rieck M; Kuboth J; Schlegel C; Grieß K; Dorweiler TF; Heiduschka S; Eckel J; Roden M; Lammert E; Stoffel M; Belgardt BF
Mol Metab; 2023 Jan; 67():101650. PubMed ID: 36470401
[TBL] [Abstract][Full Text] [Related]
18. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.
Shirakawa J; Amo K; Ohminami H; Orime K; Togashi Y; Ito Y; Tajima K; Koganei M; Sasaki H; Takeda E; Terauchi Y
J Biol Chem; 2011 Jul; 286(29):25467-76. PubMed ID: 21613229
[TBL] [Abstract][Full Text] [Related]
20. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.
Tonne JM; Sakuma T; Deeds MC; Munoz-Gomez M; Barry MA; Kudva YC; Ikeda Y
Dis Model Mech; 2013 Sep; 6(5):1236-45. PubMed ID: 23828045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
